Journal of Clinical Epidemiology
Volume 49, Issue 2 , Pages 255-261 , February 1996

Aspirin or acetaminophen? A comparison from data collected by the Spanish Drug Monitoring System

,Revised 10 April 1995

References 

  1. Peters BH, Fraim CJ, Masel BE. Comparison of 650 mg aspirin and 1000 mg acetaminophen with each other, and with placebo in moderately severe headache. Am J Med. 1983;74:36–42
  2. Telf-Hansen H, Olsen O. Paracetamol (acetaminophen) versus acetylsalicylic acid in migraine. Eur Neurol. 1980;19:163–165
  3. Parkhouse J, Hallinon P. A comparison of aspirin and paracetamol. Br J Anaesth. 1967;39:146–154
  4. Melisch DR. Review of the comparative analgesic efficacy of salicylate, acetaminophen and pyrazolones. Am J Med. 1983;14:47–52
  5. Moertel CG. Relief of pain with oral medications. Aust NZ J Med. 1976;6(Suppl. 1):1–8
  6. Bloomfield SS, Barden TP, Mitchell J. A comparison of pirprofen, aspirin, acetaminophen, placebo in postpartum uterine cramp pain. Curr Ther Res. 1981;30:S139
  7. Hurwitz ES, Barrett MJ, Bergman D, et al.  Public Health Service Study of Reye's syndrome and medications. Report of the main study. JAMA. 1987;257:1905–1911
  8. Centers for Disease Control . Reye's syndrome—United States, 1985, CDC. MMWR. 1986;36:66–74
  9. Laporte JR. Spain In:  Inman WHW editors. Drug Safety. 2nd Ed. Lancaster: MTP Press Limited; 1986;p. 143–152
  10. Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther. 1977;21:247–254
  11. Instituto Nacional de Estadística . Censo de Población 1981. Madrid: I.N.E; 1982;
  12. Gardner MJ, Altman DG. Calculating confidence intervals for proportions and their difference. In:  Gardner MJ,  Altman DG editor. Statistics with Confidence: Confidence Intervals and Statistical Guidelines. London: BMJ; 1989;p. 28–33
  13. Lee D, Bergman U. Studies of drug utilization. In:  Strom BL editors. Pharmacoepidemiology. 2nd Ed. Chichester: John Wiley & Sons; 1994;p. 379–393
  14. Hawkey CJ. Non-steroidal anti-inflammatory drugs and peptic ulcers. Br Med J. 1990;300:278–284
  15. O'Laughlin JC, Hoftiezer JW, Ivey KJ. The effect of aspirin on the human stomach in normals: Endoscopie comparison of damage produced 1 hour, 24 hours, and 2 weeks after administration. Scand J Gastroenterol. 1981;16:211–214
  16. Graham DY, Smith JL, Dobbs SM. Gastric adaptation occurs with aspirin administration in man. Dig Dis Sci. 1983;28:1–6
  17. Graham DY, Smith JL, Spjut HJ, Torres E. Gastric adaptation. Studies in humans during continuous aspirin administration. Gastroenterology. 1988;95:327–333
  18. Coggon D, Langman MJS, Speighalter D. Aspirin, paracetamol, and haematemesis and melaena. Gut. 1982;23:340–344
  19. Levy M, Miller DR, Kaufman DW, Siskind V. Major upper gastrointestinal tract bleeding. Relation to the use of aspirin and other nonnarcotic analgesics. Arch Intern Med. 1988;148:281–285
  20. Kurata JH, Corboy ED. Current peptic ulcer time trends: An epidemiological profile. J Clin Gastroenterol. 1988;10:259–268
  21. Davis M, Simmons CJ, Harrison NG, Williams R. Paracetamol overdose in man: Relationship between pattern of urinary metabolites and severity of liver damage. Q J Med. 1976;45:181–191
  22. Friis H, Andreasen PB. Drug-induced hepatic injury: An analysis of 1100 cases reported to The Danish Committee on Adverse Drug Reactions between 1978 and 1987. J Intern Med. 1992;232:133–138
  23. Fowler PD. Aspirin, paracetamol and non-steroidal anti-inflammatory drugs. A comparative review of side effects. Med Toxicol. 1987;2:338–366
  24. Prescott LF. Analgesic nephropathy. Drugs. 1982;23:75–159
  25. Sandier DP, Smith JC, Weinberg CR, Buckalew VM, Dennis VW, Blythe WB, et al. Analgesic use and chronic renal disease. N Engl J Med. 1989;320:1238–1243
  26. Pommer W, Bronder E, Greiser E, Helmert V, Jesdinsky HJ, Klimpel A, et al. Regular analgesic intake and the risk of end stage renal failure. Am J Nephrol. 1989;9:403–412
  27. Morlans M, Laporte JR, Vidal X, Capellá D, Stolley PD. End-stage renal disease and non-narcotic analgesics: A case-control study. Br J Clin Pharmacol. 1990;30:717–723
  28. Prescott LF. Antipyretic analgesics. Aspirin and the salicylates: Pancytopenia and agranulocytosis. In:  Dukes MNG editors. Meyler's Side Effects of Drugs. 8th Ed. Amsterdam: Excerpta Medica; 1975;p. 162
  29. In:  Kaufman DW,  Kelly JP,  Levy M,  Shapiro S editor. The Drug Etiology of Agranulocytosis and Aplastic Anemia. New York: Oxford University Press; 1991;
  30. Slone D, Siskind V, Heinonen OP, Monson RR, Kaufman DW, Shapiro S. Aspirin and congenital malformations. Lancet. 1976;i:1373–1375
  31. Collins E, Turner G. Maternal effects of regular salycylate ingestion in pregnancy. Lancet. 1975;2:235–339
  32. Saxen I. Associations between oral clefts and drugs taken during pregnancy. Int J Epidemiol. 1975;4:37–44
  33. Zierler S, Rothman KJ. Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. N Engl J Med. 1985;313:347–352
  34. Richards ID. Congenital malformations and environmental influence in pregnancy. Br J Prev Soc Med. 1969;23:218–225
  35. Streissguth AP, Treder RP, Barr HM, Shepard TH, Bleyer WA, Sampson PD, et al. Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements. Teratology. 1987;35:211–219
  36. Nelson MM, Forfar JO. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. Br Med J. 1971;1:523–527
  37. Steiner T. Simple analgesics in pregnancy. Br Med J. 1987;294:308
  38. Beaufils M, Uzan S, Donsimoni R, Colau JC. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet. 1985;13:840–842
  39. Uzan S, Beaufils M, Breart G. Prevention of fetal growth retardation with low-dose aspirin: Findings of the EPREDA trial. Lancet. 1991;337:1427–1431
  40. Laporte JR, Diogene E, Aragón C, Vidal X. Detección y cuantificación de reacciones adversas sobre el embrión y el feto: Estudios y registros de malformaciones congénitas. Med Clin (Barc). 1986;86:31–35
  41. Grupo de Trabajo DUP España. Estudio multicéntrico sobre el uso de medicamentos durante el embarazo en España (I). Métodos y características demográficas de la población estudiada. Med Clin (Barc). 1990;95:764–767
  42. Grupo de Trabajo DUP España. Estudio multicéntrico sobre el uso de medicamentos durante el embarazo en España (II). Los fármacos ultilizados durante la gestación. Med Clin (Barc). 1991;96:11–15
  43. Grupo de Trabajo DUP España. Estudio multicéntrico sobre el uso de medicamentos durante el embarazo en España (III). Los fármacos utilizados durante el primer trimestre de la gestación. Med Clin (Barc). 1991;96:52–57

PII: 0895-4356(95)00539-0

Journal of Clinical Epidemiology
Volume 49, Issue 2 , Pages 255-261 , February 1996

Article Tools